These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23950981)

  • 1. Pathway analysis using genome-wide association study data for coronary restenosis--a potential role for the PARVB gene.
    Verschuren JJ; Trompet S; Sampietro ML; Heijmans BT; Koch W; Kastrati A; Houwing-Duistermaat JJ; Slagboom PE; Quax PH; Jukema JW
    PLoS One; 2013; 8(8):e70676. PubMed ID: 23950981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic testing of literature reported genetic variation associated with coronary restenosis: results of the GENDER Study.
    Verschuren JJ; Trompet S; Postmus I; Sampietro ML; Heijmans BT; Houwing-Duistermaat JJ; Slagboom PE; Jukema JW
    PLoS One; 2012; 7(8):e42401. PubMed ID: 22879966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genome-wide association study identifies a region at chromosome 12 as a potential susceptibility locus for restenosis after percutaneous coronary intervention.
    Sampietro ML; Trompet S; Verschuren JJ; Talens RP; Deelen J; Heijmans BT; de Winter RJ; Tio RA; Doevendans PA; Ganesh SK; Nabel EG; Westra HJ; Franke L; van den Akker EB; Westendorp RG; Zwinderman AH; Kastrati A; Koch W; Slagboom PE; de Knijff P; Jukema JW
    Hum Mol Genet; 2011 Dec; 20(23):4748-57. PubMed ID: 21878436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinases 2 and 3 gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention: Is there still room for determining genetic variation of MMPs for assessment of an increased risk of restenosis?
    Verschuren JJ; Sampietro ML; Pons D; Trompet S; Ewing MM; Quax PH; de Knijff P; Zwinderman AH; de Winter RJ; Tio RA; de Maat MP; Doevendans PA; Jukema JW
    Dis Markers; 2010; 29(5):265-73. PubMed ID: 21206012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and study design of the CardioGene Study: genomics of in-stent restenosis.
    Ganesh SK; Skelding KA; Mehta L; O'Neill K; Joo J; Zheng G; Goldstein J; Simari R; Billings E; Geller NL; Holmes D; O'Neill WW; Nabel EG
    Pharmacogenomics; 2004 Oct; 5(7):952-1004. PubMed ID: 15469413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin type 1 receptor A1166C gene polymorphism is associated with endothelial dysfunction and in-stent restenosis after percutaneous coronary intervention.
    Li Y; Chen F; Zhang X; Gao Y; Wu C; Li H; Zhang Y
    Int J Clin Exp Pathol; 2015; 8(6):7350-7. PubMed ID: 26261635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention.
    Kullmann S; Binner P; Rackebrandt K; Huge A; Haltern G; Lankisch M; Füth R; von Hodenberg E; Bestehorn HP; Scheffold T
    BMC Cardiovasc Disord; 2009 Oct; 9():48. PubMed ID: 19814804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic risk factors for restenosis after percutaneous coronary intervention in Kazakh population.
    Zholdybayeva EV; Talzhanov YA; Aitkulova AM; Tarlykov PV; Kulmambetova GN; Iskakova AN; Dzholdasbekova AU; Visternichan OA; Taizhanova DZh; Ramanculov YM
    Hum Genomics; 2016 Jun; 10(1):15. PubMed ID: 27277665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of endothelial progenitor cells in restenosis and progression of coronary atherosclerosis after percutaneous coronary intervention: a prospective study.
    Pelliccia F; Cianfrocca C; Rosano G; Mercuro G; Speciale G; Pasceri V
    JACC Cardiovasc Interv; 2010 Jan; 3(1):78-86. PubMed ID: 20129574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detoxification and activating blood circulation decoction reduces restenosis involving the TLR4/NF-κB pathway after balloon injury.
    Zou G; Zhu J; Liu Z; Wu L; Xu R; Chen H; Deng P; Deng C
    Prostaglandins Other Lipid Mediat; 2019 Feb; 140():1-8. PubMed ID: 30453089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALOX5AP variants are associated with in-stent restenosis after percutaneous coronary intervention.
    Shah SH; Hauser ER; Crosslin D; Wang L; Haynes C; Connelly J; Nelson S; Johnson J; Gadson S; Nelson CL; Seo D; Gregory S; Kraus WE; Granger CB; Goldschmidt-Clermont P; Newby LK
    Atherosclerosis; 2008 Nov; 201(1):148-54. PubMed ID: 18374923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-coding RNAs in vascular remodeling and restenosis.
    Indolfi C; Iaconetti C; Gareri C; Polimeni A; De Rosa S
    Vascul Pharmacol; 2019 Mar; 114():49-63. PubMed ID: 30368024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear receptor Nurr1 is expressed in and is associated with human restenosis and inhibits vascular lesion formation in mice involving inhibition of smooth muscle cell proliferation and inflammation.
    Bonta PI; Pols TW; van Tiel CM; Vos M; Arkenbout EK; Rohlena J; Koch KT; de Maat MP; Tanck MW; de Winter RJ; Pannekoek H; Biessen EA; Bot I; de Vries CJ
    Circulation; 2010 May; 121(18):2023-32. PubMed ID: 20421523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of ACE insertion or deletion polymorphisms with the risk of coronary restenosis after percutaneous coronary intervention: A meta-analysis.
    Miao HW; Gong H
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):844-50. PubMed ID: 26195267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increment of HFABP Level in Coronary Artery In-Stent Restenosis Segments in Diabetic and Nondiabetic Minipigs: HFABP Overexpression Promotes Multiple Pathway-Related Inflammation, Growth and Migration in Human Vascular Smooth Muscle Cells.
    Chen K; Chen QJ; Wang LJ; Liu ZH; Zhang Q; Yang K; Wang HB; Yan XX; Zhu ZB; Du R; Zhang RY; Shen WF; Lu L
    J Vasc Res; 2016; 53(1-2):27-38. PubMed ID: 27372431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular mechanisms of vascular restenosis: Which genes are crucial?
    Bhoday J; de Silva S; Xu Q
    Curr Vasc Pharmacol; 2006 Jul; 4(3):269-75. PubMed ID: 16842144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary intervention.
    Monraats PS; Kurreeman FA; Pons D; Sewgobind VD; de Vries FR; Zwinderman AH; de Maat MP; Doevendans PA; de Winter RJ; Tio RA; Waltenberger J; Huizinga TW; Eefting D; Quax PH; Frants RR; van der Laarse A; van der Wall EE; Jukema JW
    Genes Immun; 2007 Jan; 8(1):44-50. PubMed ID: 17122782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heme oxygenase-1 gene promoter polymorphisms are associated with coronary heart disease and restenosis after percutaneous coronary intervention: a meta-analysis.
    Zhang MM; Zheng YY; Gao Y; Zhang JZ; Liu F; Yang YN; Li XM; Ma YT; Xie X
    Oncotarget; 2016 Dec; 7(50):83437-83450. PubMed ID: 27825138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic inflammatory factors predict restenosis after percutaneous coronary interventions.
    Monraats PS; Pires NM; Agema WR; Zwinderman AH; Schepers A; de Maat MP; Doevendans PA; de Winter RJ; Tio RA; Waltenberger J; Frants RR; Quax PH; van Vlijmen BJ; Atsma DE; van der Laarse A; van der Wall EE; Jukema JW
    Circulation; 2005 Oct; 112(16):2417-25. PubMed ID: 16230497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The T29C (rs1800470) polymorphism of the transforming growth factor-β1 (TGF-β1) gene is associated with restenosis after coronary stenting in Mexican patients.
    Fragoso JM; Zuñiga-Ramos J; Arellano-González M; Alvarez-León E; Villegas-Torres BE; Cruz-Lagunas A; Delgadillo-Rodriguez H; Peña-Duque MA; Martínez-Ríos MA; Vargas-Alarcón G
    Exp Mol Pathol; 2015 Feb; 98(1):13-7. PubMed ID: 25449332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.